ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: TH-PO826

Mitochondrial Quality Control Mechanisms and Fatty Acid Metabolism in Renal Cortex During the Normoalbuminuric Stage of Diabetes Mellitus

Session Information

Category: Health Maintenance‚ Nutrition‚ and Metabolism

  • 1400 Health Maintenance‚ Nutrition‚ and Metabolism

Authors

  • Ishii, Naohito, Kitasato University, Sgamihara, Japan
  • Carmines, Pamela K., University of Nebraska Medical Center, Omaha, Nebraska, United States
  • Kurosaki, Yoshifumi, Kitasato University, Sgamihara, Japan
  • Imoto, Akemi, Kitasato University, Sgamihara, Japan
  • Sugase, Taro, Seiikai Medica Clinic, Tochigi, Japan
  • Takahashi, Hiroyuki, Kitasato University, Sgamihara, Japan
  • Yokoba, Masanori, Kitasato University, Sgamihara, Japan
  • Ichikawa, Takafumi, Kitasato University, Sgamihara, Japan
  • Takenaka, Tsuneo, International University of Health & Welfare, Minato-ku, Japan
  • Katagiri, Masato, Kitasato University, Sgamihara, Japan
Background

Oxidative stress during the normoalbuminuric stage of type 1 diabetes mellitus (DM) damages renal cortical mitochondria; hence, we aimed to determine if oxidative stress in DM triggers 1) mitochondrial fission or fusion, 2) mitophagy, and/or 3) increased fatty acid (FA) metabolism.

Methods

Rats receiving streptozotocin (STZ, 65 mg/kg i.p.) or vehicle (Sham) were left untreated or treated with telmisartan (TLM, an angiotensin receptor blocker; 10 mg/kg/d). Two weeks later, blood glucose (BG), blood pressure (BP), glomerular filtration rate (GFR), and urinary excretion of albumin (UalbV) and N-acetyl-β-D-glucosaminidase (UNAGV) were measured, and the renal cortex was harvested for the following assays: HPLC was used to detect 3-NT (oxidative stress marker). Fission-, fusion-, and mitophagy-related proteins were quantified by Western blot. Levels of acylcarnitine (transports FA into mitochondria for β-oxidation) were calculated as total-minus-free carnitine levels measured by the enzymatic cycling method. GC was used to quantify ω3 FAs (α-linolenic acid, EPA & DHA) and ω6 FAs (linoleic acid & AA).

Results

BP, UalbV, and UNAGV did not differ among groups. STZ rats displayed elevated BP and GFR that were unaffected by TLM. Renal cortical samples yielded the following: The ω3/ω6 FA ratio (corrected for FA intake) and 3-NT levels were increased in STZ rats (both P<0.05 vs Sham), effects that were prevented by TLM. Acylcarnitine levels in STZ rats were higher than in Sham and were further elevated in STZ+TLM (P<0.05 vs STZ alone). STZ rats displayed TLM-sensitive increases in the mitophagy-related proteins LC3-II and PINK1 (all P<0.05), but not BNIP3 dimer or p62. Drp1 (fission marker) was 3-fold higher in STZ than in Sham, with intermediate values in STZ+TLM. Mfn2 (fusion marker) did not differ among groups.

Conclusion

During the normoalbuminuric stage of DM, renal cortical mitochondria undergo enhanced fission and mitophagy, as well as increased FA metabolism with a shift toward ω3 FAs (antioxidant & vasoprotective) relative to ω6 FAs. As these effects are blunted by TLM jointly with its antioxidant effect, they are likely quality control mechanisms triggered by oxidative damage.